Teva Pharma (TEVA) Confident in Branded Business Trends, No Plans to Raise Equity - Evercore ISI
Tweet Send to a Friend
Evercore ISI analyst Umer Raffat weighed in on Teva Pharma (NYSE: TEVA) after hosting the CEO, CFO, and IR chief ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
